Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Flattening filter free stereotactic body radiation therapy for lung tumors: outcomes and predictive factors.
Jaruthien T, Kitpanit S, Kannarunimit D, Nantavithya C, Prayongrat A, Alisanant P, Saksornchai K, Amornwichet N, Raiyava T, Chakkabat C, Lertbutsayanukul C, Khorprasert C, Shotelersuk K. Jaruthien T, et al. Among authors: kannarunimit d. Transl Cancer Res. 2021 Feb;10(2):571-580. doi: 10.21037/tcr-20-3174. Transl Cancer Res. 2021. PMID: 35116391 Free PMC article.
Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy.
Kannarunimit D, Descovich M, Garcia A, Chen J, Weinberg V, Mcguinness C, Pinnaduwage D, Murnane J, Gottschalk AR, Yom SS. Kannarunimit D, et al. Technol Cancer Res Treat. 2015 Feb;14(1):49-60. doi: 10.7785/tcrt.2012.500394. Epub 2014 Nov 11. Technol Cancer Res Treat. 2015. PMID: 24325136 Free article.
A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; preliminary result on acute adverse events.
Songthong AP, Kannarunimit D, Chakkabat C, Lertbutsayanukul C. Songthong AP, et al. Among authors: kannarunimit d. Radiat Oncol. 2015 Aug 8;10:166. doi: 10.1186/s13014-015-0472-y. Radiat Oncol. 2015. PMID: 26253488 Free PMC article. Clinical Trial.
Randomized control trial of benzydamine HCl versus sodium bicarbonate for prophylaxis of concurrent chemoradiation-induced oral mucositis.
Chitapanarux I, Tungkasamit T, Petsuksiri J, Kannarunimit D, Katanyoo K, Chakkabat C, Setakornnukul J, Wongsrita S, Jirawatwarakul N, Lertbusayanukul C, Sripan P, Traisathit P. Chitapanarux I, et al. Among authors: kannarunimit d. Support Care Cancer. 2018 Mar;26(3):879-886. doi: 10.1007/s00520-017-3904-4. Epub 2017 Sep 23. Support Care Cancer. 2018. PMID: 28942587 Clinical Trial.
A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Lertbutsayanukul C, Prayongrat A, Kannarunimit D, Chakkabat C, Netsawang B, Kitpanit S. Lertbutsayanukul C, et al. Among authors: kannarunimit d. Strahlenther Onkol. 2018 May;194(5):375-385. doi: 10.1007/s00066-017-1251-5. Epub 2018 Jan 4. Strahlenther Onkol. 2018. PMID: 29302704 Clinical Trial. English.
Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial.
Lertbutsayanukul C, Kitpanit S, Prayongrat A, Kannarunimit D, Netsawang B, Chakkabat C. Lertbutsayanukul C, et al. Among authors: kannarunimit d. J Radiat Res. 2018 Jul 1;59(4):446-455. doi: 10.1093/jrr/rry036. J Radiat Res. 2018. PMID: 29750261 Free PMC article. Clinical Trial.
28 results